real world evidence

Cost Effectiveness Modelling for Health Technology Assessment

Chris Sampson
January 13, 2025January 13, 2025

This 5-day course will provide an introduction to decision analytic cost-effectiveness modelling, giving the theoretical and practical knowledge required to design and implement analyses that meet the methodological standards of Health Technology Assessment (HTA) organisations. The programme guides you through… Read More »Cost Effectiveness Modelling for Health Technology Assessment

Chris Sampson’s journal round-up for 5th November 2018

Chris Sampson
November 5, 2018November 5, 2018
Journal round-up (category)

Every Monday our authors provide a round-up of some of the most recently published peer reviewed articles from the field. We don’t cover everything, or even what’s most important – just a few papers that have interested the author. Visit… Read More »Chris Sampson’s journal round-up for 5th November 2018

stephen black on Cost-effectiveness thresholds under political pressure: where are the health economists?
I suspect that the root cause of the problem here is not debate about the specific NICE thresholds. It is…
Andrew Briggs on Cost-effectiveness thresholds under political pressure: where are the health economists?
Excellent Chris - love the sentiment here and more to agree on than to disagree about for sure. I guess…
Chris Sampson on There is no evidence that NICE approvals cause harm
A counterfactual in this case could be commissioners not funding (or having not yet funded) the new medicine. That might…

real world evidence

Cost Effectiveness Modelling for Health Technology Assessment

Chris Sampson’s journal round-up for 5th November 2018

Research Fellow

Research Fellow

Research Fellow